Chimovits Erez

CIK 00017063995 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001706399

Recent Transactions

40 trades

Award
Upstream Bio, Inc.$UPB
Stock Option (Right to Buy)
2025-06-10+17,096→ 17,096 total
Conversion
Upstream Bio, Inc.$UPB
Common Stock
2024-10-15+721,956→ 973,716 total
Conversion
Upstream Bio, Inc.$UPB
Series B redeemable convertible preferred stock
2024-10-15−197,456→ 0 total
Purchase
Upstream Bio, Inc.$UPB
Common Stock
2024-10-15$17.00/sh+165,000→ 1,138,716 total
Conversion
Upstream Bio, Inc.$UPB
Common Stock
2024-10-15+2,887,833→ 3,894,873 total
Conversion
Upstream Bio, Inc.$UPB
Series A redeemable convertible preferred stock
2024-10-15−524,500→ 0 total
Conversion
Upstream Bio, Inc.$UPB
Series A redeemable convertible preferred stock
2024-10-15−2,098,000→ 0 total
Conversion
Upstream Bio, Inc.$UPB
Series B redeemable convertible preferred stock
2024-10-15−789,833→ 0 total
Purchase
Upstream Bio, Inc.$UPB
Common Stock
2024-10-15$17.00/sh+660,000→ 4,554,873 total
Award
Upstream Bio, Inc.$UPB
Stock Option (Right to Buy)
2024-10-10+17,096→ 17,096 total
Award
Adicet Bio, Inc.$ACET
Common Stock
2021-02-12$13.00/sh+104,050→ 396,657 total
Award
Adicet Bio, Inc.$ACET
Common Stock
2021-02-12$13.00/sh+420,299→ 5,243,259 total
Purchase
LogicBio Therapeutics, Inc.
Common Stock
2020-10-01$6.00/sh+639,212→ 4,126,972 total
Purchase
LogicBio Therapeutics, Inc.
Common Stock
2020-10-01$6.00/sh+545,974→ 3,524,997 total
Purchase
LogicBio Therapeutics, Inc.
Common Stock
2020-10-01$6.00/sh+296,296→ 296,296 total
Award
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2020-09-17+30,000→ 30,000 total
Award
Adicet Bio, Inc.$ACET
Common Stock
2020-09-15+292,607→ 292,607 total
Award
Adicet Bio, Inc.$ACET
Common Stock
2020-09-15+902,885→ 902,855 total
Award
LogicBio Therapeutics, Inc.
Stock Option (right to buy)
2020-06-19+10,000→ 10,000 total
Award
LogicBio Therapeutics, Inc.
Restricted Stock Units
2020-06-19+2,513→ 2,513 total
Award
BiomX Inc.$PHGE
Common Stock Options - Right to Buy
2020-03-25+16,000→ 16,000 total
Sale
Eledon Pharmaceuticals, Inc.$ELDN
Warrants to Purchase Common Stock
2020-01-14$0.20/sh+646,204→ 0 total
Sale
Eledon Pharmaceuticals, Inc.$ELDN
Warrants to Purchase Common Stock
2020-01-14$0.20/sh+646,204→ 0 total
Purchase
BiomX Inc.$PHGE
Common Stock, $0.001 par value
2019-12-19$8.90/sh+3,500→ 2,313,489 total
Award
LogicBio Therapeutics, Inc.
Stock Option (right to buy)
2019-12-19+10,869→ 10,869 total
Purchase
BiomX Inc.$PHGE
Common Stock, $0.001 par value
2019-12-18$8.93/sh+500→ 2,309,989 total
Purchase
BiomX Inc.$PHGE
Common Stock, $0.001 par value
2019-12-11$8.92/sh+5,400→ 2,309,489 total
Purchase
BiomX Inc.$PHGE
Common Stock, $0.001 par value
2019-12-10$8.75/sh+3,400→ 2,304,089 total
Purchase
BiomX Inc.$PHGE
Common Stock, $0.001 par value
2019-12-09$8.68/sh+6,000→ 2,300,689 total
Purchase
BiomX Inc.$PHGE
Common Stock, $0.001 par value
2019-12-06$8.00/sh+800→ 2,294,689 total
Purchase
BiomX Inc.$PHGE
Common Stock, $0.001 par value
2019-12-05$7.99/sh+3,400→ 2,293,889 total
Award
Eledon Pharmaceuticals, Inc.$ELDN
Stock Option (Right to Buy)
2019-07-11+20,000→ 20,000 total
Purchase
Eledon Pharmaceuticals, Inc.$ELDN
Warrants to Purchase Common Stock
2019-05-02+646,204→ 646,204 total
Purchase
Eledon Pharmaceuticals, Inc.$ELDN
Warrants to Purchase Common Stock
2019-05-02+646,204→ 646,204 total
Purchase
Eledon Pharmaceuticals, Inc.$ELDN
Common Stock
2019-05-02$3.10/sh+646,204→ 3,183,314 total
Conversion
LogicBio Therapeutics, Inc.
Series A Convertible Preferred Stock
2018-10-23−2,678,571→ 0 total
Conversion
LogicBio Therapeutics, Inc.
Series B Convertible Preferred Stock
2018-10-23−3,046,943→ 0 total
Conversion
LogicBio Therapeutics, Inc.
Common Stock
2018-10-23+2,997,760→ 2,997,760 total
Purchase
LogicBio Therapeutics, Inc.
Common Stock
2018-10-23$10.00/sh+490,000→ 3,487,760 total
Award
LogicBio Therapeutics, Inc.
Stock Option (right to buy)
2018-10-18+24,102→ 24,102 total

Companies

Recent Filings

Address

UPSTREAM BIO, INC. 890 WINTER STREET, SUITE 200

WALTHAM, MA, 02451

View on SEC.gov